Drug · DIN 02564327
REDEMPLO
SINGLE-USE PREFILLED SYRINGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 2, 2026; first marketed July 2, 2026.
- Drug Identification Number (DIN)
- 02564327
- Company (DIN owner)
- Arrowhead Pharmaceuticals, Inc.Pasadena, California, United States
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Other lipid modifying agents C10AX
- Class
- Human
- Record last updated
- August 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PLOZASIRAN (PLOZASIRAN SODIUM) | 25 MG | 0.5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 2, 2026: NOC 36679New Drug Submission (NDS)